Related Experiment Video
Updated: Aug 10, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Prevalence and magnitude of perinatal substance exposures in California
1School of Public Health, Center for Community Health, University of California, Berkeley 94720.
Insights
Perinatal substance exposure, including drugs, alcohol, and smoking, affects over 11% of pregnant women in California. Black women showed the highest prevalence across most substance categories.
Area of Science:
- Epidemiology
- Public Health
- Obstetrics
Background:
- Perinatal substance exposure is linked to adverse neonatal and obstetrical outcomes.
- Limited population-based studies exist on the prevalence and demographics of substance use during pregnancy.
Purpose of the Study:
- To estimate the prevalence and demographic profiles of perinatal substance exposures in California.
- To identify specific substances (drugs, alcohol, smoking) and associated risk factors.
Main Methods:
- A probabilistic, stratified-cluster sample of 29,494 women delivering in 202 California hospitals in 1992.
- Urine toxicology screening for drugs and alcohol, linked to self-reported tobacco and prescribed drug use.
- Urinary toxicology provides conservative estimates of recent substance use.
Main Results:
- Weighted prevalence: 5.16% for drugs, 6.72% for alcohol, 8.82% for smoking. 11.35% tested positive for any drug or alcohol.
- Black women exhibited the highest prevalence for total drug use (14.22%), alcohol (11.58%), cocaine (7.79%), and tobacco (20.12%).
- White non-Hispanic and Hispanic women showed significant drug and alcohol exposures, with varying prevalence rates by substance.
Conclusions:
- In 1992, an estimated 67,361 perinatal drug/alcohol exposures and 52,346 tobacco exposures occurred in California.
- Findings highlight significant clinical and public health implications for maternal and infant health.
- Disparities in prevalence across racial and ethnic groups necessitate targeted interventions.
Background:
Perinatal substance exposure has been linked to many neonatal and obstetrical complications. There have been few population-based epidemiologic studies to identify the prevalence and demographic profiles associated with drugs, alcohol, and smoking during pregnancy.
Methods:
We studied a fully probabilistic stratified-cluster sample to estimate the prevalence of perinatal substance exposures in California in 1992. Urine samples from 29,494 women presenting for delivery in 202 hospitals were coded and screened for toxins; the results of toxicology screening were later linked by code number to the subjects' demographic variables and their reported use of tobacco and prescribed drugs. Urinary toxicologic tests provide conservative estimates because they can detect only very recent substance use.
Results:
The weighted prevalence for perinatal substance exposure was 5.16 percent for the use of one or more drugs, 6.72 percent for alcohol (analyzed independently), and 8.82 percent for self-reported smoking. The percentage of women testing positive for any drug, including alcohol, was 11.35 percent. Estimates for racial and ethnic groups varied widely. Black women had the highest prevalence of total drug use (14.22 percent), alcohol use (11.58 percent), cocaine use (7.79 percent), and tobacco use (20.12 percent). Most drug exposures occurred among white non-Hispanic and Hispanic women. White non-Hispanic women had the second highest prevalence rate for the use of one or more drugs (6.79 percent) and self-reported tobacco use (14.82 percent). Hispanic women had the second highest prevalence rate for alcohol (6.87 percent).
Conclusions:
In California in 1992, there were 67,361 estimated perinatal exposures to one or more drugs, including alcohol, and 52,346 self-reported exposures to tobacco. These findings have clinical and public health implications.
More Related Videos
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Related Concept Videos
Teratogenicity
Development of the Oral Microbiota